BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Jun 29, 2009
 |  BC Extra  |  Clinical News

Innate's IPH 1101 meets HCV endpoint

Innate Pharma S.A. (Euronext:IPH) said IPH 1101 met the primary endpoint in an open-label Phase IIa trial in 25 evaluable HCV...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >